These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34561974)

  • 1. The effect of the COVID-19 pandemic on metabolic control in children with type 1 diabetes: a single-center experience.
    Sarıkaya E; Çiçek D; Gök E; Kara L; Berber U; Şiraz ÜG; Kendirci M; Hatipoğlu N
    J Pediatr Endocrinol Metab; 2022 Feb; 35(2):191-195. PubMed ID: 34561974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the State of Emergency Declaration for Severe Acute Respiratory Syndrome Coronavirus-2 Pandemic Suppression on Individuals with Type 1 Diabetes Mellitus.
    Mochizuki S; Miura J; Takagi S; Takita M; Takaike H; Babazono T
    Intern Med; 2024 May; 63(9):1197-1205. PubMed ID: 38369358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Nutritional Guidance/Consulting on Glycemic Control during the Coronavirus Disease 2019 Pandemic in Patients with Type 2 Diabetes Mellitus.
    Iwamoto Y; Nakanishi S; Iwamoto H; Sanada J; Fushimi Y; Katakura Y; Kimura T; Tatsumi F; Shimoda M; Mune T; Kaku K; Kaneto H
    Intern Med; 2023 Mar; 62(6):833-838. PubMed ID: 36631097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycated hemoglobin at diagnosis of type 1 diabetes and at follow-up in children and adolescents during the COVID-19 pandemic in Germany.
    Kamrath C; Rosenbauer J; Eckert AJ; Ohlenschläger U; Sydlik C; Nellen-Hellmuth N; Holl RW
    Pediatr Diabetes; 2022 Sep; 23(6):749-753. PubMed ID: 35366047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the COVID-19 Pandemic on Glycemic Control and Blood Pressure Control in Patients with Diabetes in Japan.
    Endo K; Miki T; Itoh T; Kubo H; Ito R; Ohno K; Hotta H; Kato N; Matsumoto T; Kitamura A; Tamayama M; Wataya T; Yamaya A; Ishikawa R; Ooiwa H
    Intern Med; 2022; 61(1):37-48. PubMed ID: 34980759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 Pandemic and Pediatric Type 1 Diabetes: No Significant Change in Glycemic Control During The Pandemic Lockdown of 2020.
    Nwosu BU; Al-Halbouni L; Parajuli S; Jasmin G; Zitek-Morrison E; Barton BA
    Front Endocrinol (Lausanne); 2021; 12():703905. PubMed ID: 34447352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of COVID-19 lockdown on glycemic control in type 1 diabetes.
    Duarte V; Mota B; Ferreira S; Costa C; Correia CC
    Arch Pediatr; 2022 Jan; 29(1):27-29. PubMed ID: 34955306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes management by either telemedicine or clinic visit improved glycemic control during the coronavirus disease 2019 pandemic state of emergency in Japan.
    Onishi Y; Yoshida Y; Takao T; Tahara T; Kikuchi T; Kobori T; Kubota T; Shimmei A; Iwamoto M; Kasuga M
    J Diabetes Investig; 2022 Feb; 13(2):386-390. PubMed ID: 33728760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of lockdown caused by the COVID-19 pandemic on glycemic control in patients with diabetes.
    Sutkowska E; Marciniak DM; Sutkowska K; Biernat K; Mazurek J; Kuciel N
    Endocrine; 2022 May; 76(2):273-281. PubMed ID: 35072900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of COVID-19 lockdown on glycaemic control and lifestyle changes in children and adolescents with type 1 and type 2 diabetes mellitus.
    Cheng HP; Wong JSL; Selveindran NM; Hong JYH
    Endocrine; 2021 Sep; 73(3):499-506. PubMed ID: 34244903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Year-long effects of COVID-19 restrictions on glycemic control and body composition in patients with glucose intolerance in Japan: A single-center retrospective study.
    Tsukaguchi R; Murakami T; Yoshiji S; Shide K; Fujita Y; Ogura M; Inagaki N
    J Diabetes Investig; 2022 Dec; 13(12):2063-2072. PubMed ID: 35980313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes care practices and outcomes in 40.000 children and adolescents with type 1 diabetes from the SWEET registry during the COVID-19 pandemic.
    Chobot A; Lanzinger S; Alkandari H; Todd Alonso G; Blauensteiner N; Coles N; De Sanctis L; Mul D; Saboo B; Smart C; Tsai MC; Zabeen B; Dovc K
    Diabetes Res Clin Pract; 2023 Aug; 202():110809. PubMed ID: 37385473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect.
    Biamonte E; Pegoraro F; Carrone F; Facchi I; Favacchio G; Lania AG; Mazziotti G; Mirani M
    Endocrine; 2021 Jun; 72(3):604-610. PubMed ID: 33950348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Race- and Neighborhood-Related Disparities Spanning the COVID-19 Pandemic: Trajectories of Combined Glycemic Control and BMI in Youth With Diabetes.
    Vajravelu ME; Mani I; Malik S; Hewitt B; Peyyety V; Arslanian S
    Diabetes Care; 2023 Mar; 46(3):511-518. PubMed ID: 36534444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight gain in type 1 diabetes during the SARS-CoV-2 pandemic. Does lockdown affect the metabolic control of pediatric patients?
    Zubkiewicz-Kucharska A; Wikiera B; Noczyńska A
    Front Endocrinol (Lausanne); 2022; 13():991269. PubMed ID: 36313778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teleconsultation for pediatric patients with type 1 diabetes mellitus during the COVID-19 pandemic: experience of a university hospital in Brazil.
    Santana YE; Liberatore RDR
    J Pediatr (Rio J); 2022; 98(6):587-589. PubMed ID: 35276099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentations, Complications, and Challenges Encountered During Management of Type 1 Diabetes in Egyptian Children During COVID-19 Pandemic: A Single-Center Experience.
    Abdou M; Hassan MM; Hassanein SA; Elsebaie EH; Shamma RA
    Front Endocrinol (Lausanne); 2022; 13():814991. PubMed ID: 35360079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Worldwide Perspective on COVID-19 and Diabetes Management in 22,820 Children from the SWEET Project: Diabetic Ketoacidosis Rates Increase and Glycemic Control Is Maintained.
    Danne T; Lanzinger S; de Bock M; Rhodes ET; Alonso GT; Barat P; Elhenawy Y; Kershaw M; Saboo B; Scharf Pinto M; Chobot A; Dovc K
    Diabetes Technol Ther; 2021 Sep; 23(9):632-641. PubMed ID: 34086503
    [No Abstract]   [Full Text] [Related]  

  • 19. Type 1 diabetes mellitus in early childhood: glycemic control and associated risk of hypoglycemic reactions.
    Lteif AN; Schwenk WF
    Mayo Clin Proc; 1999 Mar; 74(3):211-6. PubMed ID: 10089987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Living and working environments are important determinants of glycemic control in patients with diabetes during the COVID-19 pandemic: A retrospective observational study.
    Terakawa A; Bouchi R; Kodani N; Hisatake T; Sugiyama T; Matsumoto M; Ihana-Sugiyama N; Ohsugi M; Ueki K; Kajio H
    J Diabetes Investig; 2022 Jun; 13(6):1094-1104. PubMed ID: 35088564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.